Kanuni Sultan Suleyman Training and Research Hospital, Department of Anesthesia and Intensive Care, Istanbul, Turkey.
Int J Med Sci. 2012;9(5):327-33. doi: 10.7150/ijms.4222. Epub 2012 Jun 20.
The aim of this prospective, randomized, placebo-controlled study was to compare the effects of ketamine and paracetamol on preventing remifentanil induced hyperalgesia.
Ninety patients undergoing total abdominal hysterectomy were randomly assigned to one of three groups to receive (I) either saline infusion; (II) 0.5 mg/kg ketamine iv bolus or (III) 1000 mg iv paracetamol infusion before induction of anesthesia. Until the skin closure, anesthesia was maintained with 0.4 µg/kg/min remifentanil infusion in all groups, additionally Group II received 5 µg/kg/min ketamine infusion. Pressure pain thresholds were measured the day before surgery during the preoperative visit for baseline measurements and repeated postoperatively at 24 and 48 hours (hrs). Pressure pain thresholds were established by digital algometer on three different peri- incisional regions for calculating mean pressure pain threshold values. The visual analogue scale (VAS), sedation scores, total morphine consumption and side effects were assessed postoperatively.
Demographic characteristics, duration of surgery and anesthesia were similar in the three groups. Pain thresholds at the incision region were significantly lower at 24 and 48 hrs postoperatively in Group I than the other Groups (p<0.05). In Group І, pain thresholds were lower compared with preoperative baseline values. Thresholds in Group ІІ and Group ІІІ were higher compared with preoperative baseline values (p<0.05) The VAS scores at all evaluation times were significantly higher in Group І when compared to Group ІІ and at 2, 4, 6 ,12 hrs were higher in Group I than Group ІІІ (p<0.05). The morphine consumption was higher in Group ІІІ at 24 and 48 hrs postoperatively (p<0.05).
It was shown that ketamine and paracetamol were both effective in preventing remifentanil induced hyperalgesia.
本前瞻性、随机、安慰剂对照研究旨在比较氯胺酮和对乙酰氨基酚预防瑞芬太尼诱发痛觉过敏的效果。
90 例行全子宫切除术的患者被随机分为三组:(I)生理盐水组;(II)静脉注射 0.5mg/kg 氯胺酮组;(III)静脉注射 1000mg 对乙酰氨基酚组。在所有组中,直到皮肤闭合,麻醉均以 0.4μg/kg/min 瑞芬太尼输注维持,另外,在第 II 组中输注 5μg/kg/min 氯胺酮。在术前访视时测量术前一天的压力疼痛阈值作为基线测量值,并在术后 24 小时和 48 小时重复测量。通过数字压痛计在三个不同的切口区域测量压力疼痛阈值,以计算平均压力疼痛阈值。术后评估视觉模拟评分(VAS)、镇静评分、总吗啡消耗量和副作用。
三组患者的人口统计学特征、手术和麻醉持续时间相似。在术后 24 小时和 48 小时,第 I 组切口区域的疼痛阈值明显低于其他两组(p<0.05)。在第 I 组,疼痛阈值低于术前基线值。与术前基线值相比,第 II 组和第 III 组的阈值较高(p<0.05)。在所有评估时间,第 I 组的 VAS 评分均显著高于第 II 组,第 I 组在 2、4、6 和 12 小时的评分均高于第 III 组(p<0.05)。在术后 24 小时和 48 小时,第 III 组的吗啡消耗量较高(p<0.05)。
氯胺酮和对乙酰氨基酚均有效预防瑞芬太尼诱发的痛觉过敏。